PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

MACKWELL SOLUTIONS SIGNS PARTNERSHIP DEAL WITH MEDI-IMMUNE

Mackwell Solutions has entered into a deal with Medi-Immune to design, develop and manufacture a range of products based on their innovative disinfection technology, which has widespread application where protection against airborne infections is required.

Ian Mutton, Head of Mackwell Solutions, is excited about the new partnership, “We are thrilled about our partnership with Medi-Immune. A great start for the new solutions side to the Mackwell business and the catalyst for our entry into new markets. The combination of knowledge and skills between the two companies will enable us to develop some really exciting and innovative products. It’s great to work on innovations that will make a significant difference in these challenging times, and we look forward to announcing the first of these products very soon.”

Equally John Willcocks of Medi-Immune, can see a great future from the support given by the Mackwell Solutions team, “We are delighted to have formed this new partnership with Mackwell Solutions. For us it is the perfect match as Mackwell has been very quick to understand our mission and their enthusiasm and devotion is outstanding. It’s also great to be working with another like-minded British company on this.”

Medi-Immune Limited is a UK based research and development company that has set out to create ground-breaking technology to protect those who are working to protect us in pandemics, outbreaks and bioterrorism. COVID-19 Coronavirus has shocked everyone and shown the devastating changes that an easily transmissible airborne pathogen can bring. By partnering with Mackwell Solutions, Medi-Immune now has the ability to take its patented technology quickly to market and provide a valuable contribution to the health and emergency sectors. Listed as one of 20 most innovative companies to watch by Business Week in 2019, Medi-Immune has broad scientific and engineering expertise in virology, immunology, medical device technology, mechanical engineering and UV germicidal science.

Life-safety critical products are second nature to Mackwell as safety, testing and compliance is at the heart of its whole business. Mackwell Solutions assists customers in realising their product requirements, providing design and manufacturing solutions for partners. Whether working from a new product idea / concept, a developed solution or anything in between, the company offers a full turnkey solution to achieve the customer’s objectives, delivering high quality, time-efficient and cost-effective products for them. The company has comprehensive capability with on-site design and manufacturing facilities audited to BS EN ISO 9001:2015 as well as on-site laboratory and testing facilities. Mackwell has the experience and capability to understand a product sector and its relevant global approval requirements and then navigate the products developed through the approvals process in multi-national territories. 

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026